Home
Olayiwola Adekoya's picture

Olayiwola Adekoya

Associate Professor
  • E-mailOlayiwola.Adekoya@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2021). Inhibition of bacterial and human zincmetalloproteases by bisphosphonate- and catechol-containing compounds. Journal of Enzyme Inhibition and Medicinal Chemistry. 819-830.
  • Show author(s) (2018). The selectivity of galardin and an azasugar-based hydroxamate compound for human Matrix metalloproteases and bacterial metalloproteases. PLOS ONE. 28 pages.
  • Show author(s) (2016). Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors. European Journal of Medicinal Chemistry. 141-153.
  • Show author(s) (2015). Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study. Molecular Biosystems. 1041-1051.
  • Show author(s) (2015). High-level expression of pseudolysin, the extracellular elastase of Pseudomonas aeruginosa, in Escherichia coli and its purification. Protein Expression and Purification. 79-84.
  • Show author(s) (2014). Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A<sub>2</sub>, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines. Drug Design, Development and Therapy. 1405-1418.
  • Show author(s) (2014). Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors. European Journal of Medicinal Chemistry. 340-348.
  • Show author(s) (2010). Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach. Journal of Nutritional Biochemistry. 865-871.
  • Show author(s) (2009). Comparative sequence analysis of A-type inclusion (ATI) and P4c proteins of orthopoxviruses that produce typical and atypical ATI phenotypes. Virus genes. 200-209.
  • Show author(s) (2008). Theoretical calculations of the catalytic triad in short-chain alcohol dehydrogenases/reductases. Biophysical Journal.
  • Show author(s) (2006). Molecular insight into pseudolysin inhibition using the MM-PBSA and LIE methods. Journal of Structural Biology. 129-144.
  • Show author(s) (2006). Comparative sequence and structure analysis reveal features of cold adaptation of an enzyme in the thermolysin family. Proteins: Structure, Function, and Bioinformatics.
  • Show author(s) (2005). The protein-protein interactions between SMPI and thermolysin studied by molecular dynamics and MM/PBSA calculations. Journal of Biomolecular Structure and Dynamics. 521-532.
Academic chapter/article/Conference paper
  • Show author(s) (2013). Thermolsyin. 9 pages.
Abstract
  • Show author(s) (2013). Large-scale expression and purification of active pseudolysin in Escherichia coli. The FASEB Journal. 1 pages.
  • Show author(s) (2011). Molecular interactions of ABT and matrix metalloproteinases. The FEBS Journal. 322-322.
  • Show author(s) (2010). Novel Inhibitors of Matrix Metalloprotease-9 and-14. The FEBS Journal. 265-265.
Poster
  • Show author(s) (2007). Comparative sequence and structure analysis of A-tpe inclusion body (ATI) and p4c proteins of Orthopoxviruses that produce typical and atypical ATI phenotypes.
  • Show author(s) (2005). The catalytic mechanisms of short-chain dehydrogenases/ reductases.
  • Show author(s) (2005). The catalytic mechanisms of short-chain dehydrogenases/ reductases.
  • Show author(s) (2005). Structural determinants for a cold adapted enzyme in the thermolysin family.
  • Show author(s) (2002). Determination of Molecular Descriptors from Analysis of Sequence and Genome Data.
  • Show author(s) (2001). Determination of Molecular Descriptors from Analysis of Sequence and Genome Data.
Academic literature review
  • Show author(s) (2009). The Thermolysin Family (M4) of Enzymes: Therapeutic and Biotechnological Potential. Chemical Biology and Drug Design (CB&DD). 7-16.

More information in national current research information system (CRIStin)